pindolol has been researched along with Acute-Phase Reaction in 1 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
Acute-Phase Reaction: An early local inflammatory reaction to insult or injury that consists of fever, an increase in inflammatory humoral factors, and an increased synthesis by hepatocytes of a number of proteins or glycoproteins usually found in the plasma.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Maes, M | 1 |
| Van de Vyvere, J | 1 |
| Vandoolaeghe, E | 1 |
| Bril, T | 1 |
| Demedts, P | 1 |
| Wauters, A | 1 |
| Neels, H | 1 |
1 trial available for pindolol and Acute-Phase Reaction
| Article | Year |
|---|---|
Alterations in iron metabolism and the erythron in major depression: further evidence for a chronic inflammatory process.
Topics: Acute-Phase Reaction; Adrenergic beta-Antagonists; Adult; Aged; Antidepressive Agents, Second-Genera | 1996 |